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Abstract 
Patient with mental illnesses such as schizophrenia and bipolar disorder have an increased 
prevalence of metabolic syndrome (MetS) and its components compared to general 
population. Among psychiatric disorders, bipolar disorder ranks highest in suicidality with a 
relative risk ratio of completed suicide of about 25 compared to the general population. 
Regarding the biological hypotheses of suicidality, low blood cholesterol level has been 
extensively explored, although results are still conflicting. The aim of this study was to 
investigate whether there were differences in the serum cholesterol levels in hospitalized 
bipolar disorder men patients with history of suicide attempts (N=20) and without suicide 
attempts (N=20). Additionally, we investigated if there were differences in the prevalence of 
MetS according to NCEP ATP-III criteria in these two groups of patients. Results of the study 
indicated significantly lower serum cholesterol levels (p=0.013) and triglyceride levels 
(p=0.047), in the bipolar disorder men with suicide attempts in comparison to bipolar disorder 
men without suicide attempts. The overall prevalence of MetS was 11/40 (27.5%). On this 
particular sample it was higher in the non–attempters 8/20 (40.0%) than in attempters 3/20 
(15.0%) bipolar men group, but without statistical significance. Lower concentrations of 
serum cholesterol might be useful biological markers of suicidality in men with bipolar 
disorder. 
 
1. Introduction: 
 
Patient with mental illnesses such as schizophrenia and bipolar disorder have an increased 
prevalence of metabolic syndrome (MetS) and its components, risk factors for cardiovascular 
disease and type 2 diabetes (Ryan and Thakore, 2002; Newcomer, 2007 ) compared to general 
population in which incidence of MetS is also rising at an alarming rate (Nuggent, 2004). 
Although in the past years more attention has been devoted to the medical burden suffered by 
patients with schizophrenia, very recently similar concern have arisen for bipolar disorder 
patients. Previous studies on the prevalence of MetS in bipolar patients found  30% and 49% 
prevalence of MetS in US bipolar patients (Fagiolini et al., 2005; Cardenas et al., 2008), 32% 
prevalence of MetS in Turkish bipolar patients (Yumru et al., 2007) and 22.4% in Spanish 
bipolar patients (Garcia-Portilla et al., 2008). The etiology associated with this increased risk 
of MetS  in bipolar disorder is unknown. In addition to psychosocial factors  such as poverty , 
poor diet, lack of physical activities, increasing concern has focused on the association  
between second generation antipsychotics, weight gain and subsequent risk of 
hyperlipidaemia and diabetes. Patients with bipolar disorder have an additional risk for 
developing MetS because of hyperphagia and psychomotor retardation in atypical depression 
or comorbid conditions such as eating disorders, particularly within the bulimia/binge eating 
spectrum (McElroy et al., 2006).   
 
Fagiolini et al. (2005) found that bipolar patients with MetS and patients endorsing the obesity 
criterion were more likely to report a lifetime history of suicide attempts. 
 Among psychiatric disorders, bipolar disorder ranks highest in suicidality with a relative risk 
ratio of completed suicide of about 25 compared to the general population (Baldessarini and 
Tondo, 2003). During their lifetime 80% of patients with bipolar disorder exhibit suicidal 
behaviour and 51% attempt suicide (Valtonen et al., 2005). Furthermore, suicide attempts in 
bipolar patients are more lethal as one in three attempts end up with completed suicide be 
compared to a ratio of 30:1 in the general population (Baldessarini et al., 2006). Compared 
with unipolar patients, suicide attempts in bipolar patients tend to be more lethal, particularly 
in males (Zalsman et al., 2006). 
Suicidal behavior varied markedly between different phases of bipolar disorder and it is 
predominantly associated with depressive and mixed phases of the illness, rarely with pure 
manic phase. (Goldberg et al., 1999; Oquendo et al., 2000 ; Valtonen et al., 2007). 
Among the biological hypotheses of suicidality, low blood cholesterol level has been 
extensively explored, although results are still conflicting. Numerous studies showed lower 
cholesterol levels in patients hospitalized after suicide attempt as compared to non attempters 
hospitalized patients (Sarchiapone et al., 2001; Guillem et al., 2002; Kim et al., 2002) with 
remained significant difference in men, but not in women, after gender stratification (Diaz-
Sastre et al., 2007).On the other hand, there are some other studies showing no relationship 
between low cholesterol levels and suicide attempt (Roy et al., 2001; Tsai et al., 2002; 
Deisenhammer et al., 2004; Fiedorowizc et al., 2007) and even one recent study 
demonstrating higher cholesterol level in patients with suicide attempt in the past year 
(Brunner et al., 2006).  
After several studies of our team regarding the role of low cholesterol in suicidal behavior in 
different psychiatric disorders (Marčinko et al., 2004, 2005, 2007a, 2007b, 2008), the current 
study was created to investigate if serum cholesterol level is decreased in male bipolar 
disorder patients with suicide attempts compared to non-attempters. Additionally, the aim of 
this study was to estimate if there were differences in the prevalence of metabolic syndrome 
between bipolar disorder male patients with and without lifetime suicide attempts. 
 
2. Methods 
2.1. Sample 
Subjects were male patients (N=40) with bipolar disorder treated at the Department of 
Psychiatry, University Hospital Centre Zagreb during the period of 36 months. Within 
patients, 20 patients were consecutively admitted men with bipolar disorder with history of 
suicide attempt, and 20 patients were consecutively admitted men with bipolar disorder 
without history of suicide attempt. Needed sample size was calculated respected the following 
parameters: alpha error level of 95% (p<0.05), large effect size (Cohens d ≥ 0.8), infinite 
population, t-tests for two independent samples with homogenous variances). Needed sample 
size under this conditions were n=26. Due to the practical restraints (small number of patients 
that were free of medication during the last three months prior to the inclusion into the study) 
we accomplished somewhat smaller final sample (n=20). The diagnosis of bipolar disorder 
was made according to diagnostic criteria of the International Statistical Classification of 
Diseases and Related Health Problems, 10th Revision (ICD-10) , (WHO, 1996).  According to 
ICD-10 criteria in suicide attempter group 7 patients were in depressive, 5 in manic and 8 in 
mixed episode. In non attempter group 6 patients were in depressive, 12 in manic and 2 in 
mixed episode. 
 Intensity of depressive symptoms was assessed by Hamilton Depression Rating Scale, 
HDRS-17 (Hamilton, 1960), while manic symptoms were assessed by Young Mania Rating 
Scale, YMRS (Young et al., 1978). Brief Psychiatric Rating Scale (BPRS-18) was used to 
estimate a broad range of psychopathology (Overall and Gorham, 1962). Clinical Global 
Impression severity, CGI sev (Guy, 1976) was performed to asses the severity of illness, and 
Suicide Assessment Scale, SUAS for symptoms of suicidality (Stanley et al., 1986). Suicide 
attempt, by definition, included intent to die, self –harm did not count. The trained 
psychiatrist performed clinical evaluation. 
All participants were free of all  psychotropic medication for the previous 3 months. Two 
groups of patients were closely matched for age. All subjects gave written consent for 
participation in the study after detailed information about the procedures. This study was 
approved by Clinical Hospital Center Medical Ethics Committee. 
Only patients whose biochemical analyses from the time of admission were available were 
included in the study. Venous blood samples were collected within 24 h of admission. The 
exclusion criteria were: hypertension, diabetes mellitus, inherited disorders of lipoprotein 
metabolism, diagnosis of substance abuse, including alcoholism, eating disorder and organic 
brain syndrome. 
 
2.2Assesment       
Venipuncture was performed for all subjects between 8 and 9 a.m. after 12 hours overnight 
fast. Immediately after collecting blood samples, serum concentration of total cholesterol, 
High density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), 
triglycerides and serum glucose were determined using enzyme methods and commercial kits 
(Olympus Diagnostic, GmbH, Hamburg, Germany) on Olympus AU 600 automated analyzer. 
Inter- assay laboratory coefficients of variation were 3.2% for cholesterol, 2.5 for triglycerides 
and 3.0% for HDL- cholesterol. Reference intervals for the measured parameters were as 
follows: cholesterol <5.0 mmol /L, LDL <3.0 mmol /L, HDL>1.0 mmol/L, triglycerides <1.7 
mmol/L and glucose >6,1 mmol/L. 
In addition to biochemical parameters, height, weight, waist circumference and blood pressure 
were measured.  Height and weight of each patient were recorded while they were standing 
barefoot in light clothes on the medical scale that measures height and weight. Body mass 
index (BMI) was calculated that body weight in kilograms was divided with squared height 
value in meters. Waist circumference, which is considered an accurate estimate of visceral 
adiposity, was measured at minimal respiration at high point of the iliac crest and at the level 
of umbilicus. Sitting blood pressure was measured in subjects after they were interviewed in 
the sitting position for about 5 min while discussing neutral topics. 
MetS was defined according to NCEP ATP III criteria (Expert panel JAMA, 2001). The 
presence of 3 or more of the following criteria was required to meet criteria for MetS: 
1. abdominal obesity :waist circumference >102 cm in men and >88 in woman 
2. hypertrigliceridemia :≥1,7 mmol/L 
3. low HDL-cholesterol:<1,04 mmol/L in men and <1,29mmol/L in woman; 
4. high blood pressure:≥ 135/85 mm Hg; 
5. high fasting glucose:≥6,1 mmol/L  
2.3 Data analysis 
 
The results were expressed as mean values and standard deviations, 95% confidence intervals 
for means and medians. The differences in the socio-demographic variables between suicidal 
and non-suicidal groups were assessed using Chi square (χ2) test or Fisher’s exact test for 2x2 
tables. We used one-sample Kolmogorov-Smirnov test to test the normality of distributions of 
continuous variables. Depending on the result of the K-S test, we used parametric t-test for 
variables with distributions close to normal (K-S p>0.05) and nonparametric Mann-Whitney 
U test for variables with non-normal distributions (K-S p<0.05) to compare two groups of 
patients. 
Spearman correlation coefficient test was applied in searching relations between variables. In 
all tests, the criterion of significance was p<0.05. Statistical processing of results was done by 
using commercial statistical package SPSS 11 (SPSS for Windows 11.0, SPSS, Chicago, IL, 
USA).  
 
3. Results  
Results of the study are presented in Table 1. 
 
There were no statistically significant differences for age (M-W=176.5; p=0.529), BMI  (M-
W=178.0; p=0.565), waist  (M-W=155.5; p=0.231) and duration of illness  (M-W=154.0; 
p=0.221) values between bipolar male patients with and without suicide attempt.    
We did not find significant differences between suicide attempters and non-attempters 
regarding different socioeconomic measures (work status, education, marital status and 
number of children) as well as for nicotine consumption (p>0.05). The BPRS scores did not 
differ significantly between bipolar suicide attempters and non attempters  (M-W=186.5; 
p=0.718), as well as CGI severity scores  (M-W=198.5; p=0.968). 
HDRS scores were higher (M-W=144.0; p=0.134) and YMRS scores were lower (M-
W=139.5; p=0.102) in suicide attempters group than in non attempters group, but without 
statistical significance. SUAS scores were significantly higher (M-W=116.0; p=0.023) in 
attempters than in non attempters group. 
Average total cholesterol was statistical significantly lower (M-W=109.0, p=0.013) among 
suicide attempters (4.0+/-0.83) than among suicide non-attempters (5.1+/-1.58). The same 
was true in the case of triglycerides. Suicide attempters had statistically significantly lower 
(M-W=119.5, p=0.028) triglycerides levels (1.4+/-0.52) than non-attempters (2.3+/-1.74). 
Analysis showed that there are no statistically significant differences between bipolar patients 
with history of lifetime suicide attempts and bipolar patients without history of suicide 
attempts in HDL – cholesterol, LDL – cholesterol, blood pressure parameters and blood 
glucose levels (p>0.05). 
The overall prevalence of MetS in our sample was 27.5%. Among attempters group only 3 
patients met the criteria for MetS and in the group of non-attempters 8 patients met the criteria 
for MetS. Although without statistical significance, the prevalence of MetS is higher in the 
group of patients who never made a suicide attempt (p=0.155).  
Suicidality measured by SUAS was significantly positively correlated with HDRS score 
(Spearman R=0.735, p<0.001), and significantly negatively correlated with YMRS score 
(Spearman R=-0.681, p<0.001).  
Significant positive correlation was found for SUAS score and age (Spearman R=0.358, 
p=0.023), but no correlation was found for SUAS and duration of illness (p>0.05). 
We searched further for a possible correlation between SUAS score and anthropometric 
measures (BMI and waist) and did not find any significant correlation (p>0.05). 
 
4. Discussion 
4.1. Principal findings 
Results of the study showed differences between bipolar disorder male patients with and 
without suicide attempts both on biological and clinical level. Bipolar suicide attempters had 
statistically significantly lower levels of cholesterol and triglycerides compared to non 
attempters. LDL-C values were lower and HDL-C values were higher in attempters group, but 
without significance. These findings are in agreement with previous study results regarding 
low cholesterol and suicidal behavior in different psychiatric diagnostic categories 
(Sarchiapone et al., 2001; Bocchetta et al., 2001; Atmaca et al., 2002, 2007; Marčinko et al., 
2004, 2005, 2007a, 2007b, 2008). Several different mechanisms have been suggested to 
explain the potential effect of low cholesterol levels on suicidality. Low cholesterol and 
suicidality might be related to decreased 5-HT transmission (Hawton et al., 1993) and reduced 
lipid micro–viscosity in the brain cell membrane surface, resulting in decreased 5-HT receptor 
function (Engelberg, 1992), inhibited 5-HT transmission, which may lead to a poorer 
suppression of impulsive behavior or to a depressive state.  
In accordance with previous studies investigating depressive symptoms and suicidality in 
mood and/or psychotic disorders (Strakovski et al., 1996; Marčinko et al., 2008), our study 
also confirmed that suicidal patients had more pronounced depressive symptoms compared to 
non –suicidal patients, which was evident in higher HDRS scores in suicidal patients and 
positive correlation between SUAS and HDRS scores. 
The overall prevalence of MetS was 27.5% which is similar to the results of the previous 
studies investigating MetS in bipolar patients (Fagiollini et al., 2005; Yumru et al., 2007; 
Cardenas et al., 2008; Garcia –Portilla et al., 2008).   
The relatively high prevalence of Met S (27.5%) is reason for concern because syndrome has 
very highly significant health implications, including a three to five fold increased risk of 
mortality due to coronary heart disease (Alexander and al., 2003; Bonora et al., 2004) and 
sixfold risk of developing type 2 diabetes (Laaksonen et al., 2002). On the other hand , results 
of our study showed that the prevalence of MetS was higher( on this particular sample, that is 
without reaching statistical significance) in non attempters bipolar disorder group compared to 
attempters group. We hypothesized that the serum lipid levels were responsible for the 
differences in the prevalence of MetS, since there were no significant differences in other 
modal subcomponents of MetS between bipolar attempters and non–attempters group. 
Contrasting results were shown in previous study (Fagiollini et al., 2005) demonstrating 
positive correlation between the presence of MetS, and obesity in particular, and a history of 
suicide attempts. The possible explanation for these differences may lie in different age and 
gender structure of the patient's sample. The metabolic syndrome (or at least some of its 
components, especially obesity) can contribute to a worse prognosis of bipolar disorder 
through its negative impact on general physical well-beeing and functioning, quality of life, 
self esteem and psychological well-beeing (Fagiollini et al., 2003). However, some other 
components of MetS regarding hyperlipidemia may possibly have positive impact on the 
course and outcome of the disease since low lipid levels are associated with increased 
suicidality.  
To our knowledge, results of this study are the first to show relationship between reduced 
cholesterol, metabolic syndrome and suicidality in bipolar disorder. Since suicidality is 
complex behavior and influenced by biological markers and different psychological factors, 
recognizing the patients with biological predisposition to lack of behavioral control could be 
of help in prevention and treatment activities in routine clinical practice. 
 
4.2 Unanswered question and future research 
Limitations of this study are small patient sample, patients in different phases of  bipolar 
disorder  and cross sectional design which reflects only a specific moment in time. Also, there 
was no information on patient's nutritive habits, lifestyle characteristics and daily physical 
activities, as well as genetic factors, which may all contribute to the alterations in serum 
cholesterol and the presence of MetS in bipolar suicidal male patients.  
 
4.3. Conclusions 
Our results suggest that bipolar disorder male patients with suicide attempt in history have 
lower levels of serum cholesterol and triglyceride as compared to those patients without 
suicide attempt. The overall prevalence of MetS in our bipolar patient population was 27.5%. 
The presence of MetS was associated with lower frequency of suicide attempts in history of 
male patient with bipolar disorder. These results implicates that serum lipid levels may have 
important role in the neurobiology of suicide. Suicidality is a complex behavior influenced by 
many different biological and psychological parameters, so a better understanding of mutual 
relationship of these factors can facilitate more successful screening and treatment for suicidal 
patients. 
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Table 1. Differences in demographic, biological and clinical parameters between bipolar disorder men with suicide attempts (N=20) and bipolar 
disorder men without suicide attempts (N=20) 
Characteristics Suicide attempters Non attempters 
 Mean±SD* 
95% CI† 
 for mean Median Mean±SD 
95% CI 
for mean 
Median 
U‡ P 
Effect size 
(for 
significant 
results only) 
Age(years) 36.4+/-9.95 31.69-41.01 32.0 36.7+/-14.43 29.94-43.46 29.5 176.5 0.529 - 
Duration of illness /year/ 10.6+/-7.01 7.27-13.83 9.5 8.8+/-7.05 5.45-12.05 5.5 154.0 0.221 - 
BMI (kg/m²) 26.9+/-4.88 24.64-29.21 25.7 27.3+/-3.83 25.48-29.06 26.4 178.0 0.565 - 
Waist circumference (cm) 94.1+/-12.14 88.42-99.78 92.5 97.3+/-9.22 92.94-101.56 96.5 155.5 0.231 - 
Cholesterol (mmol/L) 4.0+/-0.83 3.6349-4.42 3.9 5.1+/-1.58 4.33-5.8 4.8 109.0 0.013 0.15 
Triglycerides (mmol/L) 1.4+/-0.52 1.1749-1.66 1.3 2.3+/-1.74 1.44-3.06 1.6 119.5 0.028 0.10 
LDL-c (mmol/L) 2.7+/-1.50 1.9982-3.40 2.3 3.1+/-1.32 2.46-3.7 3.0 157.5 0.253 - 
HDL-c (mmol/L) 2.3+/-2.98 0.9498-3.74 1.2 2.1+/-2.67 0.83-3.33 1.2 197.0 0.947 - 
GUK(mmol/L) 6.4+/-3.99 4.482-8.22 4.8 6.2+/-2.53 4.97-7.34 5.5 148.0 0.165 - 
CGI severity 4.5+/-1.00 4.03-4.97 5.0 4.6+/-0.76 4.19-4.91 4.5 198.5 0.968 - 
BPRS (score) 62.0+/-9.93 57.35-66.65 64.5 63.3+/-10.58 58.35-68.25 64.0 186.5 0.718 - 
HDRS-17 (score) 24.6+/-10.29 19.78-29.42 26.5 19.4+/-10.5 14.49-24.31 15.5 144.0 0.134 - 
YMRS (score) 17.7+/-15.67 10.32-24.98 14.0 26.8+/-17.25 18.73-34.87 33.0 139.5 0.102  
SUAS (score) 54.9+/-6.83 51.65-58.05 55.5 47.7+/-9.96 42.99-52.31 50.5 116.0 0.023 0.16 
* Standard deviation 
† 95% confidence interval 
‡ Mann-Whitney U test with Exact statistical significance (P) 
